Clinical trial

A Pilot Trial of Sequential Chemotherapy With Antimetabolite Induction, High-Dose Alkylating Agent Consolidation With Peripheral Blood Progenitor Cell Support, and Intensification With Paclitaxel and Doxorubicin for Patients With High-Risk Breast Cancer

NCT00001498

Drugs and interventions used in this trial

7 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Mapped RxNorm record methotrexate Normalized identity: methotrexateView linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record leucovorin Normalized identity: leucovorinView linked drug · Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention 5-fluorouracil Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record cyclophosphamide Normalized identity: cyclophosphamideView linked drug · Find medicine records · Find other trials using this name

PROCEDURE · Unmapped registry intervention peripheral blood progenitor cell Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record paclitaxel Normalized identity: paclitaxelView linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record doxorubicin Normalized identity: doxorubicinView linked drug · Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

A Pilot Trial of Sequential Chemotherapy With Antimetabolite Induction, High-Dose Alkylating Agent Consolidation With Peripheral Blood Progenitor Cell Support, and Intensification With Paclitaxel and Doxorubicin for Patients With High-Risk Breast Cancer

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date1996-02-01

PhasePHASE2

Conditions

Breast Cancerverified · MONDO: breast cancer

Breast Neoplasmsunresolved

Interventions

methotrexateDRUG · verified · RxNorm: methotrexate

leucovorinDRUG · verified · RxNorm: leucovorin

5-fluorouracilDRUG

cyclophosphamideDRUG · verified · RxNorm: cyclophosphamide

peripheral blood progenitor cellPROCEDURE

paclitaxelDRUG · verified · RxNorm: paclitaxel

doxorubicinDRUG · verified · RxNorm: doxorubicin

Sponsors & collaborators

National Cancer Institute (NCI)lead sponsor

Mapped research locations

BethesdaMaryland, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00001498 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.